ReviewCurrent topics in microbiology and immunology2025
The Human Mycobiome.
Review in Current topics in microbiology and immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacterial-fungal interactions: connections and consequences.Essays in biochemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human mycobiome refers to the fungal communities residing across body sites and plays pivotal roles in human health and disease. This chapter summarizes technical advances and current knowledge on the human mycobiome and discusses its clinical implications. Although high-throughput sequencing-based approaches have greatly improved the resolution of profiling fungal populations compared to the traditional culture-based methods, researchers should be aware of the inherent limitations of each approach and choose the most appropriate one or combination based on specific context of their study. We highlight the research progress on the composition of mycobiome and its cross talk with the host in the gastrointestinal tract, respiratory tract, oral cavity, genital tract, tumor tissues, and skin surface. The complex cross-kingdom interactions with bacteria and the emergence of new fungal pathogens-potentially driven by environment factors, emphasize the need to integrate mycobiome studies into broader microbial networks and the One Health frameworks. Together, this chapter underscores the potential of the human mycobiome as a diagnostic and therapeutic target in various diseases and advocates for interdisciplinary efforts to address the impact of fungi on human health.
Indexed as
Identifiers
40495083What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.